Renal Cancer - Results from #2180

Cracking the Case of a Deadly Type of Kidney Cancer February 26, 2021

Coffee consumption and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. February 26, 2021

Influence of treatment access on survival of metastatic renal cell carcinoma in brazilian cancer center. February 26, 2021

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma. February 25, 2021

Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma. February 25, 2021

Robot-assisted partial nephrectomy for high-complexity tumors (PADUA score ≥10): Perioperative, long-term functional and oncologic outcomes. February 25, 2021

Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients. February 24, 2021

Comorbidity and frailty assessment in renal cell carcinoma patients. February 24, 2021

Two Cases of Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinoma in Manitoba Population. February 24, 2021

Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report. February 23, 2021

Angiokines associated with outcomes after sunitinib or everolimus treatment in patients with non-clear cell renal cell carcinoma. February 23, 2021

Evaluation of oncological outcomes of robotic partial nephrectomy according to the type of hilar control approach (On-clamp vs Off-clamp), a multicentric study of the French network of research on kidney cancer-UROCCR 58-NCT03293563. February 22, 2021

Development and initial clinical testing of a multi-plexed circulating tumor cell assay in patients with clear cell renal cell carcinoma. February 22, 2021

Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma. February 19, 2021

Rapid Segmentation of Renal Tumours to Calculate Volume Using 3D Interpolation. February 19, 2021

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial. February 18, 2021

Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy. February 18, 2021

BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma. February 17, 2021

Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma. February 17, 2021

Clinical Implications of (Pro)renin Receptor (PRR) Expression in Renal Tumours. February 16, 2021

Page 110 of 457